Potential for Larger Gene Panels to Increase the Number of Molecularly Matched Therapies in Patients with Advanced Solid Tumours By Ogkologos - April 22, 2025 631 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ProfiLER-02 study Source RELATED ARTICLESMORE FROM AUTHOR Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows in China EMA Recommends Granting a Conditional Marketing Authorisation for Tovorafenib Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent Chemotherapy-Induced Thrombocytopenia MOST POPULAR Introducing our new podcast for researchers February 4, 2022 India’s First Homegrown CAR T-Cell Therapy Has Roots in NCI Collaboration February 7, 2024 Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis,... February 10, 2026 Patient Guide in Colorectal Cancer Now Available in Bulgarian February 18, 2026 Load more HOT NEWS Getting cancer services back on track during the COVID-19 pandemic EMA Recommends Granting a Marketing Authorisation for Lazertinib Fructose Fuels Cancer Growth Indirectly, Lab Study Finds Final OS and the Exploratory Analysis of the Outcome with Osimertinib...
